Overview
Coronavirus disease severity describes the range of clinical outcomes following infection, from asymptomatic or mild illness to severe respiratory failure, critical illness and death. Severity is governed by the interplay of viral factors, host characteristics such as age and comorbidity, and the intensity of the immune and inflammatory response, with excessive cytokine activity contributing to lung and systemic injury. Research relevant to severity includes cytokine profiling in hospitalised patients during the pre-storm phase of disease, the use of prognostic markers such as serum ferritin to predict in-hospital mortality, and chest computed tomography findings that reflect the extent of pulmonary involvement. Treatment evaluations, including the effect of hydroxychloroquine on clinical improvement and mortality, address how interventions influence the course of severe disease, while the molecular evolution of the virus may bear on the virulence of circulating lineages. Severity also has epidemiological and statistical dimensions, reflected in analyses of pandemic data and risk of death in defined populations. Understanding the determinants of disease severity supports risk stratification, appropriate allocation of care, and the development of therapies that target the mechanisms driving progression, helping clinicians distinguish patients likely to deteriorate from those expected to recover with supportive management.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
As Evidenced by the Statistics of the Pandemic
COVID-19 Pandemic: The Causative Agent is New, The Problem is Old
The Impact of Chest Computed Tomography in A Covid-19 Reference Hospital - First Wave - Distrito Federal - Brazil
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
Potential Impact of COVID-19 Outbreak on Education, Staff Development and Training in Africa
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
How this research is being cited
The 12 articles above have been cited 16 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2024 · International Journal of Social health
-
Lufti Hajri et al. · 2024 · International Journal of Social Health
-
2024 · Archives of Pulmonology and Respiratory Care
-
2022 · International Journal of Clinical Virology
A sample of recent works citing this journal's research on Coronavirus Disease Severity, linking to each citing work.